Quent Capital, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
Quent Capital, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$1,733
-18.8%
3180.0%0.00%
Q2 2023$2,134
-24.0%
3180.0%0.00%
Q1 2023$2,808
+15.6%
3180.0%0.00%
Q4 2022$2,430
+21.5%
318
+28.7%
0.00%
Q3 2022$2,000
-33.3%
247
+28.0%
0.00%
-100.0%
Q1 2022$3,0001930.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2022
NameSharesValueWeighting ↓
Matrix Capital Management Company, LP 15,115,090$419,897,00010.74%
TIGER MANAGEMENT L.L.C. 1,115,411$30,986,00010.41%
Robertson Stephens Wealth Management, LLC 537,095$14,920,0005.10%
VIKING GLOBAL INVESTORS LP 33,493,708$930,455,0004.84%
Senator Investment Group LP 3,388,085$94,121,0003.41%
Casdin Capital, LLC 793,125$22,033,0002.34%
Iron Triangle Partners LP 150,000$4,167,0001.61%
Aristotle Atlantic Partners, LLC 370,841$10,302,0001.57%
Crewe Advisors LLC 93,000$2,584,0001.54%
PERSONAL CFO SOLUTIONS, LLC 112,916$3,137,0001.13%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders